|
|||||
|
|
Off-label Use of Itolizumab in Patients with COVID-19 ARDS: Our Clinical Experience in a Dedicated COVID Center |
|
| Authors: | Poonam Kumari Amarjeet Kumar Chandni Sinha Ajeet Kumar Prabhat K Singh SK Arun |
| Affiliation: | 1,3,4,6Department of Anaesthesiology, All India Institute of Medical Sciences, Patna, Bihar, India;2.Department of Trauma and Emergency, All India Institute of Medical Sciences, Patna, Bihar, India;5.Director, All India Institute of Medical Sciences, Patna, Bihar, India |
| Abstract: | |
| Keywords: | Acute respiratory distress syndrome (ARDS) COVID-19 Cytokine storm Itolizumab Monoclonal antibody |